Dipole Density Mapping of Typical Atrial Flutter
- Conditions
- Atrial Flutter
- Interventions
- Device: Acutus Medical System Mapping
- Registration Number
- NCT01914497
- Lead Sponsor
- Acutus Medical
- Brief Summary
Study to determine the feasibility of the Acutus Medical System in obtaining data to create Dipole Density Maps of electrical activation in the right atrium in patients with typical atrial flutter.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3
- Be aged 18 to 75 years
- Be scheduled for ablation of typical atrial flutter (cavotricuspid isthmus dependent)
- Be able and willing to give informed consent
-
Have any of the following:
1.1 Patients with implanted prosthetic, artificial, or repaired cardiac valves in the chamber being mapped.
1.2 Patients with permanent pacemaker or ICD leads in the chamber being mapped. 1.3Patients with hypercoagulopathy or an inability to tolerate anticoagulation therapy during an electrophysiology procedure.
-
Require treatment in the left atrium and/or a require a transseptal puncture to access the left atrium during the index procedure
-
Have had a myocardial infarction within the prior two months
-
Have had cardiac surgery within the prior three months
-
Have an intracardiac thrombus
-
Have clinically significant tricuspid valve regurgitation or stenosis
-
Have had any cerebral ischemic event (including transient ischemic attacks) in the prior six months
-
Be pregnant or nursing
-
Be currently enrolled in any other clinical investigation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Acutus Medical System Acutus Medical System Mapping Proprietary software algorithms will be used generate electrical activation maps based dipole density data acquired by the Acutus Medical Catheter during the procedures. These activation maps will then be applied to a 3D model of the endocardial surface to create a 3D activation map.
- Primary Outcome Measures
Name Time Method Incidence of device-and procedure-related adverse events 7 days The number of patients in which offline construction of pre- and post-treatment activation maps can be completed 7 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Universitätsklinikum Hamburg-Eppendorf
🇩🇪Hamburg, Germany